ADIAL PHARMACEUTICALS, INC. 10-K filing
Filed 2026-03-05 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001213900-26-024175
- Form type
- 10-K
- CIK
- 0001513525
- Primary document
- https://www.sec.gov/Archives/edgar/data/1513525/000121390026024175/ea0279150-10k_adial.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for ADIAL PHARMACEUTICALS, INC..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-7.8M | - | - |
| Net Income | $-8.0M | - | - |
| Eps Basic | -11.93 | - | - |
| Eps Diluted | -11.93 | - | - |
| Cash And Equivalents | $5.9M | - | - |
| Total Assets | $6.7M | - | - |
| Total Liabilities | $1.4M | - | - |
| Shareholders Equity | $5.3M | - | - |
| Operating Cash Flow | $-6.5M | - | - |